Oppenheimer & Co’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-14,000
Closed -$167K 1569
2015
Q1
$167K Sell
14,000
-4,141
-23% -$50.6K ﹤0.01% 1349
2014
Q4
$232K Buy
+18,141
New +$231K 0.01% 1143
2014
Q3
Sell
-11,748
Closed -$189K 1504
2014
Q2
$189K Buy
+11,748
New +$183K 0.01% 1270
2014
Q1
Sell
-20,000
Closed -$309K 1486
2013
Q4
$309K Buy
+20,000
New +$295K 0.01% 1001
2013
Q3
Sell
-70,213
Closed -$909K 1384
2013
Q2
$909K Buy
+70,213
New +$941K 0.04% 542

Other funds holding MDRX

Oppenheimer & Co's MDRX Position: Q2 2015 in Review

Oppenheimer & Co sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2015, closing a stake of 14,000 shares — an estimated $167K sold.

Oppenheimer & Co first reported a position in MDRX in Q2 2013 and held it in 5 quarters. The position peaked at $909K in Q2 2013. 234 funds tracked by Wall St. Rank hold MDRX as of Q2 2015.

  • Oppenheimer & Co reported no remaining Veradigm Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 14,000 Veradigm Inc. Common Stock shares in Q2 2015, an estimated $167K.
  • Oppenheimer & Co first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 5 quarters.
  • Oppenheimer & Co's Veradigm Inc. Common Stock position peaked at $909K in Q2 2013.
  • 234 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2015.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.